Dr. Nicholas Alexander Borja, MD

Dr. Borja practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Borja's NPI, 1982995015, was assigned on April 24, 2011. Dr. Borja graduated from Perelman School of Medicine - Philadelphia in 2011. Dr. Borja holds Florida license ME-137924.

Dr. Borja's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Borja's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Borja to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Borja practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Borja's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Borja is board certified in clinical genetics and genomics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Borja's licenses on file in 2 states: Florida and Texas.

CMS data shows 18 Medicare services from Dr. Borja across 1 procedure code in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $2,765 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Borja in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Borja's median patient age at 46, with 68% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Borja for performance year 2024, reported as part of a group. Dr. Borja accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Borja as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Borja, published from 2015 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Phenotype and Intellectual Disability. Dr. Borja has published most often in Am J Med Genet A. Dr. Borja's most frequent co-authors are Mustafa Tekin, MD, Guney Bademci, MD and Jean Jingzhi Bao, MD.

CMS Open Payments shows 1 general payment to Dr. Borja from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $24.

Dmand AI lists 1 award for Dr. Borja, most recently Ruth L. Kirschstein National Research Service Award in 2016.

Dr. Borja graduated from Perelman School of Medicine - Philadelphia in 2011. Dr. Borja is a member of American College of Medical Genetics and AMA.

Dr. Borja is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. POS plans come from the most carriers, 4. Check the plan with the practice before a visit.